跳至主要内容
临床试验/NCT04081285
NCT04081285已完成不适用

Identification of Epigenetic Biomarkers for Alzheimer's Disease in Blood Using Epigenome-wide Analysis

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2019年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
250
试验地点
1
主要终点
DNA methylation

研究概览

简要总结

Alzheimer's disease (AD) is a neurodegenerative disorder with no know cure. The pathogenesis of late onset AD (LOAD) is complex and multifactorial in nature, with multiple susceptibility genes and environmental factors at interplay.

The objective of this study is to improve our understanding of the risk factors of LOAD by conducting an epigenome wide study within patients of LOAD contrasted against their cognitively normal siblings.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Sufficient Cantonese competency for cognitive test
  • Written informed consent given
  • Have at least one gender-matched cognitively normal sibling

排除标准

  • Subjects who refuse blood taking procedure
  • Do not have a reliable family/caregiver informant (personal contact at least once a month)

结局指标

主要结局

DNA methylation

时间窗: 5 years

RNA-seq microbiome

时间窗: 5 years

Alzheimer's disease Assessment Scale-cognitive subscale (Adas-Cog)

时间窗: 5 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Timothy Kwok

Professor

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验